Skip to content

Left Ventricular Lead Position in Cardiac Resynchronization Therapy

Optimal Definition of Left Ventricular Lead Position in Cardiac Resynchronization Therapy by Myocardial Deformation Imaging

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00748735
Enrollment
55
Registered
2008-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2008-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

cardiac resynchronization therapy, echocardiography, heart failure, left ventricular function, pacing, myocardial deformation imaging, Optimal Definition of Left Ventricular Lead Position in Cardiac Resynchronization Therapy

Brief summary

Left ventricular (LV) lead position has crucial impact on cardiac resynchronization therapy (CRT) success. This study will compare fluoroscopy and myocardial deformation imaging for optimal definition of LV lead position.

Detailed description

In a 16 segment model circumferential strain will be used to determine the segment with latest peak systolic circumferential strain prior to CRT, considered as the optimal LV lead target. LV lead will be defined by (1) fluoroscopy, (2) the maximal temporal difference of peak circumferential strain before-to-on CRT and (3) the earliest peak systolic circumferential strain during LV pacing. For all 3 modalities optimal LV lead position is defined as concordance or immediate neighbouring of the segment with defined LV lead position to the determined optimal target segment. At follow-up echocardiography will be performed to determine improvement in LV function and remodeling.

Interventions

PROCEDUREImplantation of a cardiac resynchronization therapy device
PROCEDUREEchocardiography (myocardial deformation imaging)

Sponsors

RWTH Aachen University
Lead SponsorOTHER

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* See above * Males and females * Ages 18 to 80 years

Exclusion criteria

* Patients who already have had a pacemaker device * Patients with poor echocardiographic window * Patients who are not able to understand the study and to give informed written consent

Design outcomes

Primary

MeasureTime frame
Improvement in LV function and LV remodelling6 to 12 months

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 31, 2026